Procaps Group appoints new board directors
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Procaps Group SA (PROCF)
Procaps Group SA stock price live, this page displays OTC PROCF stock exchange data. View the PROCF premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Procaps Group SA real time stock price chart below.
What Is the Procaps Group SA Stock Price Today?
The Procaps Group SA stock price today is 1.100.
What Is the Stock Symbol for Procaps Group SA?
The stock symbol for Procaps Group SA is ""PROCF.""
What Stock Exchange Does Procaps Group SA Trade On?
Procaps Group SA is listed and trades on the OTC Markets stock exchange.
Is Procaps Group SA a Good Stock to Buy?
Determining whether Procaps Group SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PROCF quote. (ISIN: LU2376511205)
What Is the Procaps Group SA Stock Price Today?
The Procaps Group SA stock price today is 1.100.
What Is the Stock Symbol for Procaps Group SA?
The stock symbol for Procaps Group SA is ""PROCF.""
What Stock Exchange Does Procaps Group SA Trade On?
Procaps Group SA is listed and trades on the OTC Markets stock exchange.
Is Procaps Group SA a Good Stock to Buy?
Determining whether Procaps Group SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PROCF quote. (ISIN: LU2376511205)
OTC Markets
Currency in USD
1.100
0.000(0.00%)
Closed·
Fair Value
An estimate of a Procaps's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.100
1.100
52 wk Range
0.010
3.775
PROCF Scorecard
Full Analysis
Stock generally trades with high price volatility
PROCF is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Procaps's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.1001.100
52 wk Range
0.0103.775
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
PROCF Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Procaps's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
- Procaps Group appoints new board directors
- Investing.com
- Procaps Group Receives Delisting Notice From Nasdaq
- Investing.com
- Procaps Group Receives Additional Delinquency Letter
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Sell
Procaps Group SA Company Profile
Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory. It also provides drugs for hospital use, such as antibiotic, blood clot, personal protective equipment, immunosuppressant, oncology, and analgesics products. In addition, the company offers over-the-counter (OTC) consumer healthcare products through a portfolio on approximately eight therapeutic areas, including gastrointestinal, skin care, cough and cold, analgesics, urological, vitamins, minerals, and supplements in the categories of antibiotics, anti-infective, anti-parasitic, cardiovascular, feminine care, cutaneous antimycotic, pain killers, gastro intestinal, hormonals, metabolic, endocrine, nervous system, ophthalmic, osteoarticular, respiratory, diet supplements, and vitamins and minerals. Further, it provides blood glucose meters, telemonitoring products, oral anti-diabetics products, cosmeceuticals, insulin delivery systems, and other diabetes solutions; and contract drug development and manufacturing services to third party pharmaceutical companies, specializing in soft gelatin capsule technologies. The company was founded in 1977 and is based in Luxembourg, Luxembourg.
Compare PROCF to Peers and Sector
Metrics to compare | PROCF | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPROCFPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | 13.0x | −0.5x | |
PEG Ratio | 0.00 | 0.01 | 0.00 | |
Price/Book | 0.0x | 1.4x | 2.6x | |
Price / LTM Sales | 0.0x | 2.1x | 3.3x | |
Upside (Analyst Target) | 0.0% | 106.4% | 45.4% | |
Fair Value Upside | Unlock | 27.4% | 7.7% | Unlock |
Earnings
Latest Release
May 30, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Stock Exchange Does Procaps Trade On?
Procaps is listed and trades on the OTC Markets stock exchange.
What Is the Stock Symbol for Procaps?
The stock symbol for Procaps is "PROCF."
What Is the Procaps Market Cap?
As of today, Procaps market cap is 2.53B.
What Is Procaps's Earnings Per Share (TTM)?
The Procaps EPS (TTM) is 0.52.
When Is the Next Procaps Earnings Date?
Procaps will release its next earnings report on 01 Sept 2025.
From a Technical Analysis Perspective, Is PROCF a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Procaps Stock Split?
Procaps has split 0 times.
How Many Employees Does Procaps Have?
Procaps has 5500 employees.
What is the current trading status of Procaps (PROCF)?
As of 03 Aug 2025, Procaps (PROCF) is trading at a price of 1.10, with a previous close of 1.10. The stock has fluctuated within a day range of 1.10 to 1.10, while its 52-week range spans from 0.01 to 3.78.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.